Synthesis, antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclopentane ring. Part 2: Adenosine and uridine analogues

Nucleosides and Nucleotides

Volumn 17, Issue 7, 1998, Pages 1255-1266

  Nieto, M I ^a   Blanco, J M ^a   Caamano O ^a   Fernandez F ^a   Garcia Mera X ^a   Balzarini, J ^b   Padalko, E ^b   Neyts, J ^b   De Clercq, E ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 CHLORO 9H PURIN 9 YLMETHYL) 1,2,2 TRIMETHYLCYCLOPENTYLMETHANOL; 3 DEAZAARISTEROMYCIN; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ACICLOVIR; ADENOSINE DERIVATIVE; AMANTADINE; ANTIVIRUS AGENT; CARBOCYCLIC NUCLEOSIDE; CYCLOPENTANE DERIVATIVE; CYTOSTATIC AGENT; GANCICLOVIR; RIBAVIRIN; RIMANTADINE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFLUENZA VIRUS B; LEUKEMIA CELL; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMALIA; HUMAN INFLUENZA VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS B;

EID: 0031749477     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004237     Document Type: Article

References (14)

1. Part 1: Blanco, J.M., Caamaño, O., Fernández, F., Gómez, G., Nieto, M.I, Balzarini, J., Padalko, E., De Clercq, E., Nucleosides & Nucleotides, 1997, 16, 159-171.
2. For recent reviews of the literature on the synthesis of CANs, see: a) Agrafoglio, L., Suhas, E., Farese, A., Condom, R., Challand, S.R., Earl, R.A., Guedj, R., Tetrahedron, 1994, 50, 10611-10670; b) Borthwick, A.D., Biggadike, K., Tetrahedron, 1992, 48, 571-623; Huryn, D.M., Okaba, M., Chem. Rev., 1992, 50, 1745-1768.
3. For recent reviews of the literature on the synthesis of CANs, see: a) Agrafoglio, L., Suhas, E., Farese, A., Condom, R., Challand, S.R., Earl, R.A., Guedj, R., Tetrahedron, 1994, 50, 10611-10670; b) Borthwick, A.D., Biggadike, K., Tetrahedron, 1992, 48, 571-623; Huryn, D.M., Okaba, M., Chem. Rev., 1992, 50, 1745-1768.
4. For recent reviews of the literature on the synthesis of CANs, see: a) Agrafoglio, L., Suhas, E., Farese, A., Condom, R., Challand, S.R., Earl, R.A., Guedj, R., Tetrahedron, 1994, 50, 10611-10670; b) Borthwick, A.D., Biggadike, K., Tetrahedron, 1992, 48, 571-623; Huryn, D.M., Okaba, M., Chem. Rev., 1992, 50, 1745-1768.
5. Coates, J.A.V., Ingall, H.J., Pearson, B.A., Penn, C.R., Storer, R., Williamson, C., Cameron, J.M., Antiviral. Res., 1991, 15, 161-168,
6. a) De Clercq, E., Biochem. Pharmacol., 1987, 36, 2567-2575;
7. b) Cools, M., De Clercq, E., Biochem. Pharmacol., 1989, 38, 1061-1067.
8. Caamaño, O., Fernández, F., Gómez, G., Nieto, M.I, Tetrahedron, 1994, 50, 2175-2182.
9. Patil, S.D., Koga, M., Schneller, S.W., J. Med. Chem., 1992, 35, 2191-2195.
10. Vince, R., Daluge, S., J. Org. Chem., 1980, 45, 531-533.
11. Shaw, G., Warrener, R. N., J. Chem. Soc., 1958, 157-161.
12. Shaw, G., Warrener, R. N., J. Chem. Soc., 1958, 153-156.9.
13. Shealy, Y.F., O'Dell, C.A., J. Heterocycl. Chem., 1976, 13, 1041.
14. De Clercq, E., in "In vitro and ex vivo test systems to rationalize drug design and delivery", D. Crommelin, P. Couvreur, D. Duchêne (Eds.), Editions de Santé, Paris, France, 1994, pp 108-125.